PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 172 filers reported holding PORTOLA PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $15,460,000 | +362.2% | 859,389 | +83.2% | 0.00% | +300.0% |
| Q1 2020 | $3,345,000 | -77.9% | 469,183 | -25.9% | 0.00% | -75.0% |
| Q4 2019 | $15,126,000 | -5.1% | 633,416 | +6.5% | 0.00% | -20.0% |
| Q3 2019 | $15,947,000 | +6.0% | 594,588 | +7.2% | 0.01% | 0.0% |
| Q2 2019 | $15,046,000 | -26.2% | 554,588 | -5.6% | 0.01% | -28.6% |
| Q1 2019 | $20,380,000 | +77.8% | 587,353 | 0.0% | 0.01% | +75.0% |
| Q4 2018 | $11,465,000 | -26.7% | 587,353 | 0.0% | 0.00% | -20.0% |
| Q3 2018 | $15,641,000 | -24.8% | 587,353 | +6.7% | 0.01% | -28.6% |
| Q2 2018 | $20,794,000 | -16.3% | 550,521 | -27.7% | 0.01% | -22.2% |
| Q1 2018 | $24,858,000 | -26.5% | 761,107 | +9.6% | 0.01% | -25.0% |
| Q4 2017 | $33,810,000 | -9.9% | 694,537 | 0.0% | 0.01% | -14.3% |
| Q3 2017 | $37,526,000 | +9.0% | 694,537 | +13.3% | 0.01% | 0.0% |
| Q2 2017 | $34,435,000 | +101.6% | 613,052 | +40.6% | 0.01% | +100.0% |
| Q1 2017 | $17,085,000 | +70.1% | 435,947 | -2.6% | 0.01% | +75.0% |
| Q4 2016 | $10,046,000 | +3.5% | 447,681 | 0.0% | 0.00% | -20.0% |
| Q3 2016 | $9,710,000 | +4.4% | 447,681 | +13.6% | 0.01% | +25.0% |
| Q2 2016 | $9,301,000 | +15.7% | 394,119 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $8,040,000 | -66.8% | 394,119 | -16.3% | 0.00% | -66.7% |
| Q4 2015 | $24,228,000 | +35.0% | 470,906 | +11.8% | 0.01% | +33.3% |
| Q3 2015 | $17,947,000 | +191.6% | 421,100 | +211.6% | 0.01% | +200.0% |
| Q2 2015 | $6,155,000 | +53.4% | 135,134 | +27.8% | 0.00% | +50.0% |
| Q1 2015 | $4,013,000 | +67.8% | 105,721 | +14.5% | 0.00% | +100.0% |
| Q1 2014 | $2,392,000 | +0.6% | 92,358 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $2,378,000 | -3.8% | 92,358 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $2,471,000 | – | 92,358 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Grace Capital | 270,832 | $6,467,000 | 5.27% |
| Fernwood Investment Management, LLC | 336,111 | $8,026,000 | 3.84% |
| Tamarack Advisers, LP | 595,000 | $14,268,000 | 3.26% |
| First Light Asset Management, LLC | 1,008,957 | $24,094,000 | 3.08% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,540,679 | $36,791,000 | 2.79% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,133,343 | $50,944,000 | 2.25% |
| SECTORAL ASSET MANAGEMENT INC | 606,189 | $14,476,000 | 2.16% |
| Asymmetry Capital Management, L.P. | 49,431 | $1,180,000 | 2.12% |
| Parkman Healthcare Partners LLC | 275,505 | $6,579,000 | 1.90% |
| HARVEY CAPITAL MANAGEMENT INC | 150,751 | $3,599,000 | 1.60% |